UiPath Inc
NYSE:PATH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
UiPath Inc
NYSE:PATH
|
US |
|
Kko International SA
PAR:ALKKO
|
BE |
|
B
|
British American Tobacco PLC
XBER:BMT
|
UK |
|
Samsung Electronics Co Ltd
F:SSUN
|
KR |
|
Swatch Group AG
F:UHRN
|
CH |
|
M
|
Mitsui Chemicals Inc
XMUN:MSI
|
JP |
|
Maxlinear Inc
NASDAQ:MXL
|
US |
|
Relief Therapeutics Holding SA
OTC:RLFTF
|
CH |
|
C
|
Costco Wholesale Corp
XMUN:CTO
|
US |
Wall St Price Targets
PATH Price Targets Summary
UiPath Inc
According to Wall Street analysts, the average 1-year price target for PATH is 13.59 USD with a low forecast of 11.09 USD and a high forecast of 17.85 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PATH's stock price target?
Price Target
13.59
USD
According to Wall Street analysts, the average 1-year price target for PATH is 13.59 USD with a low forecast of 11.09 USD and a high forecast of 17.85 USD.
What is the Revenue forecast for UiPath Inc?
Projected CAGR
9%
Over the last 6 years, the compound annual growth rate for Revenue has been 30%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for UiPath Inc?
Projected CAGR
109%
The compound annual growth rate for Operating Income over the next 3 years is 109%.
What is the Net Income forecast for UiPath Inc?
Projected CAGR
25%
The compound annual growth rate for Net Income over the next 3 years is 25%.
